Head-to-Head

Immunic, Inc. Common Stock vs. Eli Lilly & Co.

IMUX

Immunic, Inc. Common Stock

$8.08 +1.25%

VS LLY

Eli Lilly & Co.

$1373.70 +6.63%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

IMUXLLY
Market Cap $108.88 million $1.15 trillion

LLY leads on 1 of 1 size & scale factors.

Dividend

IMUXLLY
Dividend Yield — 0.50%

IMUX and LLY split the dividend factors evenly.

Risk & Sentiment

IMUXLLY
Short Interest 2.84% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: IMUX overview, IMUX financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.